Literature DB >> 21258014

Diagnosis and management of hereditary angioedema.

Douglas T Johnston1.   

Abstract

Hereditary angioedema (HAE) is characterized by sudden attacks of deep tissue swelling caused by C1 inhibitor deficiency. Swelling severity can vary from mild to severe, and some patients are at risk for disability and death from either asphyxiation or hypovolemic shock. Many HAE attacks are precipitated by trauma or stress. The extremities, genitalia, trunk, bowels, face, and larynx are commonly affected areas, but swelling can affect any single part of the body or multiple sites. Symptoms typically worsen over 24 to 36 hours and resolve within 48 hours. Because many symptoms of HAE overlap with those of other medical conditions, diagnosis may be delayed. A thorough family history can identify the signature symptoms of HAE, which include a family history of HAE, recurrent edema without urticaria, and symptomatic worsening during puberty. The author presents two hypothetical cases of HAE and reviews the clinical hallmarks of this condition, diagnostic tests, and available treatments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258014

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  13 in total

1.  Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings.

Authors:  Emel Aygören-Pürsün; Daniel Soteres; Dumitru Moldovan; Jim Christensen; Arthur Van Leerberghe; James Hao; Jennifer Schranz; Kraig W Jacobson; Inmaculada Martinez-Saguer
Journal:  Int Arch Allergy Immunol       Date:  2017-06-30       Impact factor: 2.749

2.  Perioperative management for patients with hereditary angioedema.

Authors:  Anesu H Williams; Timothy J Craig
Journal:  Allergy Rhinol (Providence)       Date:  2015-01

Review 3.  Diagnosis and screening of patients with hereditary angioedema in primary care.

Authors:  Maria Paula Henao; Jennifer L Kraschnewski; Theodore Kelbel; Timothy J Craig
Journal:  Ther Clin Risk Manag       Date:  2016-05-02       Impact factor: 2.423

Review 4.  Breakthroughs in hereditary angioedema management: a systematic review of approved drugs and those under research.

Authors:  Stefania Nicola; Giovanni Rolla; Luisa Brussino
Journal:  Drugs Context       Date:  2019-10-02

5.  Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey.

Authors:  Anette Bygum; Teresa Caballero; Anete S Grumach; Hilary J Longhurst; Laurence Bouillet; Werner Aberer; Andrea Zanichelli; Jaco Botha; Irmgard Andresen; Marcus Maurer
Journal:  Clin Transl Allergy       Date:  2019-07-19       Impact factor: 5.871

Review 6.  Complement diagnostics: concepts, indications, and practical guidelines.

Authors:  Bo Nilsson; Kristina Nilsson Ekdahl
Journal:  Clin Dev Immunol       Date:  2012-11-14

7.  Hereditary angioedema: A rare cause of recurrent abdominal pain.

Authors:  Xi Chen; Ying Xue Yang; Yu Lan Liu; Hua Tian Gan; Zhong Hui Wen
Journal:  Pak J Med Sci       Date:  2014-09       Impact factor: 1.088

8.  Risk of angioedema following invasive or surgical procedures in HAE type I and II--the natural history.

Authors:  E Aygören-Pürsün; I Martinez Saguer; W Kreuz; T Klingebiel; D Schwabe
Journal:  Allergy       Date:  2013-08       Impact factor: 13.146

Review 9.  Angioedema: Classification, management and emerging therapies for the perioperative physician.

Authors:  Lopa Misra; Narjeet Khurmi; Terrence L Trentman
Journal:  Indian J Anaesth       Date:  2016-08

10.  Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.

Authors:  H J Longhurst; A Zanichelli; T Caballero; L Bouillet; W Aberer; M Maurer; O Fain; V Fabien; I Andresen
Journal:  Clin Exp Immunol       Date:  2017-02-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.